Inoue Akira 井上彰

… Alternative Names

Researcher Number	70361087
Other IDs
Affiliation (Current)	2019: 東北大学, 医学系研究科, 教授
Affiliation (based on the past Project Information) *help	2017 – 2019: 東北大学, 医学系研究科, 教授 2017: 東北大学, 大学病院, 教授 2014: 東北大学, 病院, 准教授 2012: 東北大学, 大学病院, 特任准教授 2012: 東北大学, 病院, 特任准教授 … More
Review Section/Research Field	Principal Investigator Respiratory organ internal medicine / General internal medicine(including psychosomatic medicine) / Society medicine, Nursing, and related fields Except Principal Investigator Respiratory organ internal medicine / Biological Sciences / Medium-sized Section 58:Society medicine, nursing, and related fields
Keywords	Principal Investigator 緩和医療 / 自然免疫 / NK細胞 / RAE-1 / アデノウイルスベクター / 遺伝子導入 / 薬剤性肺障害 / 肺癌 / ゲフィチニブ / EGFR阻害剤 … More Except Principal Investigator 肺腺癌 / EGF受容体 / 肺線維症 / EGFR / SLPI / 肺発癌 / 自然免疫 / ノックアウトマウス / EGFR特異変異 / 非喫煙者 / ゲノム / 東アジア / EGFR遺伝子変 / ゲノム解析研究 / EGFR受容体 / 非閉塞性肺疾患 / 呼吸器感染症 / Fibrocyte / 循環線維細胞 / micro RNA / 間質性肺炎 / バイオマーカー / 肺幹細胞 / miRNA / SP-D / 非閉塞性肺疾患癌 / 家族性癌 / エクソーム解析 / 細気管支上皮細胞 / 不死化 / 発癌 / がん遺伝子依存 / 分子標的薬 / 細胞内シグナル伝達 / EGF receptor / lung adenocarcinoma / bronchiolar epithelial cell / anti-apoptotic / tumorigenesis / oncogene addiction / molecular targeting drugs / intracellular signaling / 間葉系幹細胞 / エピジェネティクス / 酸化ストレス / ERストレス / 障害ストレス応答 / 成長因子 / 老化 / STC1 / SASP / マクロファージ / ミトコンドリア / エピゲノム / メタボローム / がん免疫療法看護 / がん患者 / 質評価 / 指標開発 Less

がん免疫療法看護の質評価指標開発に向けた探索的研究Ongoing
- Principal Investigator
  
  佐藤冨美子
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 58:Society medicine, nursing, and related fields
- Research Institution
  Tohoku University
がん悪液質による食欲不振・倦怠感に対する薬物療法の複合的研究Principal InvestigatorOngoing
- Principal Investigator
  
  井上彰
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General internal medicine(including psychosomatic medicine)
- Research Institution
  Tohoku University
進行肺がん患者における抗がん剤治療の止めどきに関する多施設共同研究Principal InvestigatorOngoing
- Principal Investigator
  
  井上彰
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Challenging Research (Exploratory)
- Research Field
  
  Society medicine, Nursing, and related fields
- Research Institution
  Tohoku University
Differantial Mechanism of Lung Cells induced by Mesenchymal Stem Cells and the Treatment of Intractable Respiratory Diseases
- Principal Investigator
  
  Ohkouchi Shinya
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University
Familial pathogenesis of lung cancer with the epidermal growth factor receptor (EGFR) gene mutation
- Principal Investigator
  
  KIKUCHI Toshiaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University
Pathogenesis and control of circulating fibrocytes and miRNAs causing interstitial/airway fibrosis and initiating/promoting cancer in the lung
- Principal Investigator
  
  EBINA Masahito
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University
Individualized treatment of lung cancer based on the resistant mutation in EGFR gene from circulating tumor cellsPrincipal Investigator
- Principal Investigator
  
  INOUE Akira
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University
Biological background for non-smoker lung adenocarcinoma : Why do EGFR somatic mutations accumulate on lung adenocarcinoma and on Asian ethnics?
- Principal Investigator
  
  NUKIWA Toshihiro
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University
The analysis of mechanisms of interstitial lung disease induced by epidermal growth factor receptor inhibitor.Principal Investigator
- Principal Investigator
  
  INOUE Akira
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University
肺腺癌EGFRキナーゼ活性型変異株はなぜ蛋白分解酵素阻害物質SLPIを高産生するか
- Principal Investigator
  
  NUKIWA Toshihiro
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Tohoku University
Activation mutations in EGF receptor kinase have the advantages of cell physiology in the bronchiolar region : Implication of anti-apoptotic signals and lung tumorigenesis and metastasis.
- Principal Investigator
  
  NUKIWA Toshihiro
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  TOHOKU UNIVERSITY
NKG2Dリガンド遺伝子導入による抗腫瘍効果増強の検討Principal Investigator
- Principal Investigator
  
  井上彰
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University

All 2018 2017 2015 2013 2012 2011 2010 2009 2008 2007 2006 2005 Other

All Journal Article Presentation

[Journal Article] Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis.2018
- Author(s)
  Hirano T, Ohkouchi S, Tode N, Kobayashi M, Ono M, Satoh T, Mitsuishi Y, Watanabe A, Tabata M, Irokawa T, Ogawa H, Sugiura H, Kikuchi T, Akasaka K, Tazawa R, Inoue Y, Nakata K, Kurosawa H, Ichinose M.
- Journal Title
  
  ERJ Open Research.
  
  Volume: 4 Pages: 00071-2017
- DOI
  10.1183/23120541.00071-2017
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K09205, KAKENHI-PROJECT-15K15316, KAKENHI-PROJECT-15K15321
[Journal Article] Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer2017
- Author(s)
  Tode N, Kikuchi T, Sakakibara T, Hirano T, Inoue A, Ohkouchi S, Tamada T, Okazaki T, Koarai A, Sugiura H, Niihori T, Aoki Y, Nakayama K, Matsumoto K, Matsubara Y, Yamamoto M, Watanabe A, Nukiwa T, Ichinose M.
- Journal Title
  
  Cancer Science
  
  Volume: 印刷中 Pages: 1263-1270
- DOI
  10.1111/cas.13233
- Peer Reviewed / Open Access / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16H05307, KAKENHI-PROJECT-26293059, KAKENHI-PROJECT-26293195, KAKENHI-PROJECT-15K14473, KAKENHI-PROJECT-16K14664, KAKENHI-PROJECT-16K15453, KAKENHI-PROJECT-17K16037, KAKENHI-PROJECT-17H04180, KAKENHI-PROJECT-15K09205, KAKENHI-PROJECT-15K15316
[Journal Article] Peripheral Alveolar Nitric Oxide Concentration Reflects Macrophage Inflammation in Auto-Immune Pulmonary Alveolar Proteinosis2017
- Author(s)
  Taizou Hirano, Shinya Ohkouchi, Naoki Tode, Makoto Kobayashi, Manabu Ono, Teruyuki Satoh, Yoichiro Mitsuishi, Akira Watanabe, Masao Tabata, Toshiya Irokawa, Hiromasa Ogawa, Hisatoshi Sugiura, Toshiaki Kikuchi, Keiichi Akasaka, Ryushi Tazawa, Yoshikazu Inoue, Koh Nakata, Hajime Kurosawa and Masakazu Ichinose
- Journal Title
  
  ERJ open research
  
  Volume: 印刷中
- Acknowledgement Compliant / Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09205
[Journal Article] A Semiquantitative CT Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis2017
- Author(s)
  Sayoko Tokura, Masanori Akira, Tomohisa Okuma, Ryushi Tazawa, Toru Arai, Chikatoshi Sugimoto, Toshinori Takada, Koh Nakata, Haruyuki Ishii, Yasunori Kasahara, Masayuki Hojo, Shinya Ohkouchi, Yoshikazu Inoue
- Journal Title
  
  Ann Am Thorac Soc
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09205
[Journal Article] A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosis2015
- Author(s)
  Akasaka K, （12名略）， Tazawa R, (7名略) Nakata K.
- Journal Title
  
  Am J Physiol Lung Cell Mol Physiol.
  
  Volume: 308 Pages: 105-117
- DOI
  10.1152/ajplung.00239.2014
- Peer Reviewed / Open Access / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-22242001, KAKENHI-PROJECT-24406027, KAKENHI-PROJECT-25461153, KAKENHI-PROJECT-15K09205
[Journal Article] Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.2015
- Author(s)
  Keiichi Akasaka, Takahiro Tanaka, Nobutaka Kitamura, Shinya Ohkouchi, Ryushi Tazawa, Toshinori Takada, Toshio Ichiwata, Etsuro Yamaguchi, Masaki Hirose, Toru Arai, Kentaro Nakano, Takahito Nei, Haruyuki Ishii, Tomohiro Handa, Yoshikazu Inoue and Koh Nakata
- Journal Title
  
  BMC pulmonary medicine
  
  Volume: 15 Pages: 15-15
- DOI
  10.1186/s12890-015-0085-0
- Peer Reviewed / Open Access / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09203, KAKENHI-PROJECT-15K09205, KAKENHI-PROJECT-15K15321, KAKENHI-PROJECT-15H04829, KAKENHI-PROJECT-25461153, KAKENHI-PROJECT-26305028
[Journal Article] Impact of epidermal growth factor receptor inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis2013
- Author(s)
  Lee CK, Brown C, Inoue A, et al
- Journal Title
  
  J Natl Cancer I
  
  Volume: 105 Pages: 595-605
- DOI
  10.1093/jnci/djt072
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Interstitial Lung Disease associated with Gefitinib in Japanese Patients with EGFR MutatedNon-Small Cell Lung Cancer: Combined analysis of two phase III trials (NEJ 002 and WJTOG 3405)2013
- Author(s)
  Akamatsu H, Inoue A, Mitsudomi T, et al
- Journal Title
  
  Jpn Clin Oncol
  
  Volume: 43 Pages: 664-8
- DOI
  10.1093/jjco/hyt049
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] LUX-Lung 4: A Phase II Trial of Afatinib in Patients withAdvanced, Non-Small Cell Lung Cancer who progressed on Prior Treatment with Erlotinib, Gefitinib, or Both2013
- Author(s)
  Katakami N, Atagi S, Inoue A, et al
- Journal Title
  
  J Clin Oncol
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-Naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).2013
- Author(s)
  Inoue A, Kobayashi K, Maemondo M, et al
- Journal Title
  
  Ann Oncol.
  
  Volume: 24 Pages: 54-59
- DOI
  10.1093/annonc/mds214
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-23591132, KAKENHI-PROJECT-24240042, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24659396
[Journal Article] First-Line Gefitinib in Patients Aged 75 or Older With Advanced Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: NEJ 003 Study2012
- Author(s)
  Maemondo M, Minegishi Y, Inoue A, et al
- Journal Title
  
  J Thorac Oncol
  
  Volume: 7 Pages: 1417-22
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22895139
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] 肺がんの分子標的治療薬2012
- Author(s)
  井上彰
- Journal Title
  
  日本老年医学会雑誌
  
  Volume: 49 Pages: 8-13
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Miliary brainmetastases in 2cases with advanced non-small cell lung cancer harboring EGFR mutation during gefitinib treatment.2012
- Author(s)
  Mochizuki S, Nishimura N, Inoue A, et al
- Journal Title
  
  Respir Investig
  
  Volume: 50 Pages: 117-121
- DOI
  10.1016/j.resinv.2012.06.002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis2012
- Author(s)
  Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R
- Journal Title
  
  Eur Respir J
  
  Volume: 39 Pages: 777-780
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390164
[Journal Article] Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma2012
- Author(s)
  Wong WF
- Journal Title
  
  Br J Cancer
  
  Volume: 188 Pages: 129-134
- DOI
  10.1038/bjc.2012.422
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390164, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24592826
[Journal Article] for the North-East Japan Study Group and the ALK Lung Cancer Study Group. A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non-Small Cell Lung Cancer.2012
- Author(s)
  Soda M, Isobe K, Inoue A, Maemondo M,Oizumi S, Fujita Y, Gemma A, Yamashita Y,Ueno T, Takeuchi K, Choi YL, Miyazawa H,Tanaka T, Hagiwara K, Mano H
- Journal Title
  
  Clin Canc.Res
  
  Volume: 18 Pages: 5682-5689
- DOI
  10.1158/1078-0432.ccr-11-2947
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300326, KAKENHI-PROJECT-22680063, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-23689043, KAKENHI-PROJECT-24591184
[Journal Article] Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of NEJ 002 Trial.2012
- Author(s)
  Oizumi S, Kobayashi K, Inoue A, Maemondo M, Sugawara S, Yoshizawa H, Isobe H, Harada M, Kinoshita I, Okinaga S, Kato T, Harada T, Gemma A, Saijo Y, Yokomizo Y, Morita S, Hagiwara K, Nukiwa T.
- Journal Title
  
  Oncologist
  
  Volume: 17 Pages: 863-70
- DOI
  10.1634/theoncologist.2011-0426
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591006, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24659396
[Journal Article] Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib2011
- Author(s)
  Asahina H, Oizumi S, Inoue A, Kinoshita I, Ishida T, Fujita Y, Sukoh N, Harada M, Maemondo M, Saijo Y, Dosaka-Akita H, Isobe H, Nukiwa T, Nishimura M
- Journal Title
  
  Oncology
  
  Volume: 79 Pages: 423-429
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Randomized Phase II Study of Two Schedules of Carboplatin and Gemcitabine for Stage IIIB and IV Advanced Non-Small Cell Lung Cancer (JACCRO LC-01 Study)2011
- Author(s)
  Imamura F, Inoue A, 6番目, et al
- Journal Title
  
  Chemotherapy
  
  Volume: 57 Pages: 357-362
- DOI
  10.1159/000330481
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations2011
- Author(s)
  Satoh H, Inoue A, Kobayashi K, Maemondo M, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizawa H, Hagiwara K, Nukiwa T
- Journal Title
  
  J Thorac Oncol
  
  Volume: 6 Pages: 1413-1417
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Inhaled Granulocyte/Macrophage-Colony Stimulating Factor as Therapy of Pulmonary Alveolar Proteinosis.2011
- Author(s)
  Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ishii H, Yokoba M, Tanaka N, Yamaguchi E, Eda R, Tsuchihashi Y, Morimoto K, Akira M, Terada M, Otsuka J, Ebina M, et al
- Journal Title
  
  Am J Respir Crit Care Med
  
  Volume: 181 Pages: 1345-1354
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390164
[Journal Article] Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling2011
- Author(s)
  Chmielecki J, Foo J, Inoue A, et al
- Journal Title
  
  Sci Transl Med
  
  Volume: 3
- DOI
  10.1126/scitranslmed.3002356
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Low-dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations2011
- Author(s)
  Satoh H, Inoue A, et al
- Journal Title
  
  J Thorac Oncol
  
  Volume: 6 Pages: 1413-1417
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Phase II study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib2011
- Author(s)
  Asahina H, Oizumi S, Inoue A, et al
- Journal Title
  
  Oncology-BASEL
  
  Volume: 79 Pages: 423-429
- DOI
  10.1159/000326488
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Low-dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations2011
- Author(s)
  Satoh H, Inoue A, Kobayashi K, Maemondo M, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizawa H, Hagiwara K, Nukiwa T
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 6(8) Pages: 1413-1417
- DOI
  10.1097/jto.0b013e31821d43a8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591006, KAKENHI-PROJECT-22659160, KAKENHI-PROJECT-22790746
[Journal Article] Low-Does Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations2011
- Author(s)
  Satoh H, Inoue A, Kobayashi K, Maemondo M, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizaka H, Hagiwara K, NukiwaT
- Journal Title
  
  J Thorac Oncol
  
  Volume: 6 Pages: 1413-1417
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] North-East Japan Study Group : Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR2010
- Author(s)
  Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nuiwa T
- Journal Title
  
  N Engl J Med
  
  Volume: 362 Pages: 2380-2388
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.2010
- Author(s)
  Maemondo M, Inoue A, et al
- Journal Title
  
  N Engl J Med
  
  Volume: 362 Pages: 2380-2388
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Randamized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer2010
- Author(s)
  Sakakibara T, Inoue A, Sugawara, et al
- Journal Title
  
  Ann Oncol 4
  
  Pages: 800-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer : North Japan Lung Cancer Study Group Trial 04052010
- Author(s)
  Inoue A, Ishimoto O, Fukumoto S, Usui K, Suzuki T, Yokouchi H, Maemondo M, Kanbe M, Ogura S, Harada T, Oizumi S, Harada M, Sugawara S, Fukuhara T, Nukiwa T
- Journal Title
  
  Ann Oncol
  
  Volume: 21 Pages: 800-803
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Ann Oncol2010
- Author(s)
  Inoue A, Ishimoto 0, Fukumoto S, Usui K, Suzuki T, Yokouchi H, Maemondo M, Kanbe M, Ogura S, Harada T, Oizumi S, Harada M, Sugawara S, Fukuhara T, Nukiwa T(North Japan Lung Cancer Study Group trial 0405 )
- Journal Title
  
  A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.
  
  Volume: 21 Pages: 800-803
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Gefitinib or chemortherapy for non-small-cell lung cancer with mutated EGFR.2010
- Author(s)
  Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nuiwa T, North-East Japan Study Group
- Journal Title
  
  N Engl Med.
  
  Volume: 362 Pages: 2380-2388
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Randomized, phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer.2010
- Author(s)
  Sakakibara T, Inoue A, et al
- Journal Title
  
  Ann Oncol
  
  Volume: 21 Pages: 795-799
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.North Japan Lung Cancer Study Group Trial 0405.2010
- Author(s)
  Inoue A, et al
- Journal Title
  
  Ann Oncol
  
  Volume: 21 Pages: 800-803
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746
[Journal Article] Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for eldely patients with advanced non-small-cell lung cancer2010
- Author(s)
  Sakakibara T, Inoue A, Sugawara S, Maemondo M, Ishida T, Usui K, Abe T, Kanbe M, Watanabe H, Saijo Y, Nukiwa T
- Journal Title
  
  Ann Oncol
  
  Volume: 27 Pages: 795-799
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] (North Japan Lung Cancer Study Group trial 0405): A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer2009
- Author(s)
  Inoue A, Ishimoto O, Fukumoto S, Usui K, Suzuki T, Yokouchi H, Maemondo M, Kanbe M, Ogura S, Harada T, Oizumi S, Harada M, Sugawara S, Fukuhara T, Nukiwa T
- Journal Title
  
  Ann Oncol
  
  Volume: 21 Pages: 800-803
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] First-line Gefitinib for Advanced Non-Small Cell Lung Cancer Patients Harboring Epidermal Growth Factor Receptor Mutations without Indication for Chemotherapy.2009
- Author(s)
  Inoue A, et al
- Journal Title
  
  J Clin Oncol 27
  
  Pages: 1394-1400
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] First-line gefitinib for patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.2009
- Author(s)
  Inoue A, Kobayashi K, Usui K, et al
- Journal Title
  
  J Clin Oncol 27
  
  Pages: 1394-1400
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Randomized phaseIItrial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with calboplatin for elderly patients with advanced non-small-cell lung cancer2009
- Author(s)
  Sakakibara T, Inoue A, Sugawara S, Maemondo M, Ishida T, Usui K, Abe T, Kanbe M, Watanabe H, Saijo Y, Nukiwa T
- Journal Title
  
  Ann Oncol
  
  Volume: 21 Pages: 795-799
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] North East Japan Gefitinib Study Group : First-line Gefitinib for patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy2009
- Author(s)
  Inoue A, Kobayashi K, Usui K, Maemondo M, Okinaga S, Mikami I, Ando M, Yamazaki K, Saijo Y Gemma A, Miyazawa H, Tanaka T, Ikebuchi K, Nukiwa T, Morita S, Hagiwara K
- Journal Title
  
  J Clin Oncol
  
  Volume: 27 Pages: 1394-1400
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations2009
- Author(s)
  Morita S, Okamoto I, Kobayashi K, Yamazaki K, Asahina H, Inoue A, Hagiwara K, Sunaga N, Yanagitani N, Hida T, Yoshida K, Hirashima T, Yasumoto K, Sugio K, Mitsudomi T, Fukuoka M, Nukiwa T
- Journal Title
  
  Clin Cancer Res
  
  Volume: 15 Pages: 4493-4498
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21249052
[Journal Article] First-line Gefitinib for Advanced Non-Small Cell Lung Ca ncer Patients Harboring Epidermal Growth Factor Recept or Mutations without Indication for Chemotherapy2009
- Author(s)
  Inoue A
- Journal Title
  
  J Clin Oncol 27
  
  Pages: 1394-1400
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.2008
- Author(s)
  Maruyama R, ・・・, Inoue A, et al
- Journal Title
  
  J Clin Oncol 26
  
  Pages: 4244-4252
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Randomized Phase II Trial Comparing Amrubicin with Topotecan in Patients with Previously Treated Small Cell Lung Cancer: Report of North Japan Lung Cancer Study Group Trial 0402.2008
- Author(s)
  Inoue A, et al
- Journal Title
  
  J Clin Oncol 26
  
  Pages: 5401-5406
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.2008
- Author(s)
  Fukuhara T, ・・・, Inoue A, et al
- Journal Title
  
  Tohoku J Exp Med 214
  
  Pages: 359-363
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] siRNA targeting against EGFR, a promising candidate for a novel therapeutic application to lung adenocarcinoma.2008
- Author(s)
  Yamanaka S, ・・・, Inoue A, et al
- Journal Title
  
  Pathobiology 75
  
  Pages: 2-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Sensitive and Specific New Enzyme-Linked Immunosorbent Assay for N-ERC/Mesothelin Increases its Potential as a Useful Serum Tumor Marker for Mesothelioma.2008
- Author(s)
  Shiomi K, ・・・, Inoue A, et al
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 1431-1437
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Adenocarcinoma with epidermal growth factor receptor gene mutations in three siblings.2008
- Author(s)
  Sakakibara T,・・・,Inoue A, et al
- Journal Title
  
  J Thorac Oncol 3
  
  Pages: 311-313
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Randomized Phase II Trial Comparing Amrubicin with To potecan in Patients with Previously Treated Small Cell L ung Cancer : Report of North Japan Lung Cancer Study G rout Trial 04022008
- Author(s)
  Inoue A
- Journal Title
  
  J Clin Oncol 26
  
  Pages: 5401-5406
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Suppression of surfactant protein A by an epidermal grow th factor receptor tyrosine kinase inhibitor exacerbates lu ng inflammation2008
- Author(s)
  Inoue A
- Journal Title
  
  Cancer Sci 99
  
  Pages: 1679-1684
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation.2008
- Author(s)
  Inoue A, et al
- Journal Title
  
  Cancer Sci 99
  
  Pages: 1679-1684
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790552
[Journal Article] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer2006
- Author(s)
  Inoue A
- Journal Title
  
  Lung Cancer 52
  
  Pages: 83-87
- Data Source
  KAKENHI-PROJECT-16790443
[Journal Article] A prospective phase II study of gefitinib for chemo-naive patients with advanced non-small cell lung cancer with epidermal growth factor receptor gene mutations2006
- Author(s)
  Inoue A, et al.
- Journal Title
  
  J Clin Oncol. (印刷中)
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.2006
- Author(s)
  Inoue A. et al.
- Journal Title
  
  Lung Cancer. 52・1
  
  Pages: 83-87
- Data Source
  KAKENHI-PROJECT-18012008
[Journal Article] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.2006
- Author(s)
  Inoue A. et al.
- Journal Title
  
  Lung Cancer 52・1
  
  Pages: 83-87
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.2006
- Author(s)
  Inoue A. et al.
- Journal Title
  
  J Clin Oncol. 24・21
  
  Pages: 3340-3346
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations2006
- Author(s)
  Inoue A. et al.
- Journal Title
  
  J Clin Oncol. 24・21
  
  Pages: 3340-3346
- Data Source
  KAKENHI-PROJECT-18012008
[Journal Article] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.2006
- Author(s)
  Inoue A., et al.
- Journal Title
  
  J Clin Oncol. 24・21
  
  Pages: 3340-3346
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.2006
- Author(s)
  Inoue A., et al.
- Journal Title
  
  Lung Cancer. 52・1
  
  Pages: 83-87
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] Gene mutations in lung cancer promising predictive factors for the success of molecular therapy.2005
- Author(s)
  Inoue A. et al.
- Journal Title
  
  PLoS Med. 2・1
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] Gene mutations in lung cancer : promising predictive factors for the success of molecular therapy.2005
- Author(s)
  Inoue A. et al.
- Journal Title
  
  PLoS Med. 2・1
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17390240
[Journal Article] Gene mutations in lung cancer : promising predictive factors for the success of molecular therapy2005
- Author(s)
  Inoue A
- Journal Title
  
  PLoS Med 2
- Data Source
  KAKENHI-PROJECT-16790443
[Journal Article] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.2005
- Author(s)
  Inoue A. et al.
- Journal Title
  
  Lung Cancer. 52・1
  
  Pages: 83-87
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17390240
[Presentation] The Analysis Of Alveolar Macrophage Form On BALF Specimens In Secondary Pulmonary Alveolar Proteinosis2015
- Author(s)
  Haruyuki Ishii, , Ryushi Tazawa, Yoshikazu Inoue, Takeshi Saraya, Takashi Koide, Tomohiro Handa, Masato Morita, Shigeki Yamamoto, Yoshinori Tanino, Shinya Ohkouchi, Keisuke Tomii, Koh Nakata
- Organizer
  ATS2015
- Place of Presentation
  United States of America(Denver)
- Year and Date
  2015-05-15
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09205
[Presentation] A Mathematical Model that Estimates the Amount of Eliminated GM-CSF Autoantibody by Whole-Lung Lavage in Autoimmune Pulmonary Alveolar Proteinosis2015
- Author(s)
  Takahiro Tanaka, Keiichi Akasaka, Takashi Maruyama, Nobutaka Kitamura, , Atsushi Hashimoto, Keiko Shiiya, Yuuko Itoh, Shinya Ohkouchi, Ryushi Tazawa, Etsuro Yamaguchi, Toshio Ichiwata, Masaki Hirose, Toru Arai, Yoshikazu Inoue, Hirosuke Kobayashi, Koh Nakata
- Organizer
  ATS2015
- Place of Presentation
  United States of America(Denver)
- Year and Date
  2015-05-15
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09205
[Presentation] 肺癌治療に関連する臨床的な知見2013
- Author(s)
  井上彰
- Organizer
  第32回日本画像医学会教育講演15
- Place of Presentation
  東京
- Year and Date
  2013-02-23
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] クリゾチニブによる薬剤性肺障害を発症した後、同剤を再投与した一例2013
- Author(s)
  井上彰、ほか
- Organizer
  第96回日本呼吸器学会東北地方会
- Place of Presentation
  秋田
- Year and Date
  2013-03-23
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 進行肺がんの薬物療法2012
- Author(s)
  井上彰
- Organizer
  第7回医療の質・安全学会学術集会シンポジウム10
- Place of Presentation
  大宮
- Year and Date
  2012-11-24
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 臨床論文の書き方2012
- Author(s)
  井上彰
- Organizer
  第7回日本緩和医療薬学会教育セミナー
- Place of Presentation
  東京
- Year and Date
  2012-06-29
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Randomized phase II trial comparing carboplatin with weekly paclitaxel and docetaxel alone for elderly patients with non-small cell lung cancer:NJLCG08032012
- Author(s)
  井上彰、ほか
- Organizer
  第10回日本臨床腫瘍学会International session7
- Place of Presentation
  大阪
- Year and Date
  2012-07-28
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] クリゾチニブによる急性肺障害の一例2012
- Author(s)
  井上彰、ほか
- Organizer
  第51回日本肺癌学会東北支部会
- Place of Presentation
  弘前
- Year and Date
  2012-07-21
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] EGFR2012
- Author(s)
  井上彰
- Organizer
  第38回肺癌診断会シンポジウム2
- Place of Presentation
  越後湯沢
- Year and Date
  2012-06-23
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 分子標的治療2012
- Author(s)
  井上彰
- Organizer
  第29回日本呼吸器外科学会総会教育講演
- Place of Presentation
  秋田
- Year and Date
  2012-05-17
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] EGFR-TKIが教えてくれたこと2012
- Author(s)
  井上彰
- Organizer
  第53回日本肺癌学会総会シンポジウム1
- Place of Presentation
  岡山
- Year and Date
  2012-11-08
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Evidences ofEGFR-targeted therapy for NSCLC in Asia2011
- Author(s)
  Inoue A
- Organizer
  16^<th> Congress of APSR (Symposium 16)
- Place of Presentation
  Shanghai, China
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 東北大学病院におけるEML4-ALK融合遺伝子陽性肺癌の臨床的特徴2011
- Author(s)
  小林誠、榊原智博、井上彰、貫和敏博
- Organizer
  第52回日本肺癌学会
- Place of Presentation
  大阪、日本
- Year and Date
  2011-11-03
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] 肺癌の分子標的治療の進歩(EGFR-TKI)2011
- Author(s)
  井上彰
- Organizer
  第52回日本肺癌学会シンポジウム1
- Place of Presentation
  大阪
- Year and Date
  2011-11-03
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Clinical Aspects Of Non-Small Cell Lung Cancer Harboring EML4-ALK Fusion Gene In Tohoku University Hospital2011
- Author(s)
  Sakakibara T, Inoue A, Fukuhara T, Sasaki T, Nukiwa T
- Organizer
  American Thoracic Society International Conference
- Place of Presentation
  Denver
- Year and Date
  2011-05-15
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] Evidences of EGFR-targeted therapy for NSCLC in Asia2011
- Author(s)
  Inoue A.
- Organizer
  16^<th> Congress of APSR
- Place of Presentation
  Shanghai、中国
- Year and Date
  2011-11-05
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA)plus paclitaxel (TXL) as the first-line treatment for advanced non-smallcell lung cancer (NSCLC) with EGFR mutations2011
- Author(s)
  Inoue A, Kobayashi K, Maemondo M, et al
- Organizer
  ASCO annual meeting
- Place of Presentation
  Chicago, USA
- Year and Date
  2011-06-06
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 非小細胞肺癌における最近の分子標的治療薬の動向2011
- Author(s)
  井上彰
- Organizer
  第93回日本肺癌学会関西支部会
- Place of Presentation
  神戸
- Year and Date
  2011-02-19
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] III期局所進行切除不能非小細胞肺癌に対するCDDP+ UFT(UP)とCDDP+ VNR(NP)併用化学放射線療法の無作為化比較第二相試験2011
- Author(s)
  臼井一裕, 菅原俊一, 前門戸任, 石田卓, 榊原智博, 井上彰, 石本修, 松原信行, 西條康夫, 貫和敏博
- Organizer
  第51回日本呼吸器学会学術講演会
- Place of Presentation
  東京
- Year and Date
  2011-04-24
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] Molecular mechanisms of resistance to EGFR-TKI2011
- Author(s)
  Inoue A
- Organizer
  16^<th> Congress of APSR (Symposium 18)
- Place of Presentation
  Shanghai, China
- Year and Date
  2011-11-06
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 肺癌の臨床における抗EGFR療法の展開2011
- Author(s)
  井上彰
- Organizer
  第9回日本臨床腫瘍学会シンポジウム03
- Place of Presentation
  横浜
- Year and Date
  2011-07-22
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations2011
- Author(s)
  Inoue A, Kobayashi K, Maemondo M, et al
- Organizer
  ASCO annual meeting 2011
- Place of Presentation
  Chicago、アメリカ
- Year and Date
  2011-06-04
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] What we can do after present TKI failure-Acquired resistance?2010
- Author(s)
  Inoue A
- Organizer
  TSPCCM annual meeting
- Place of Presentation
  台北,台湾
- Year and Date
  2010-12-11
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Recent topics about theindividualized treatment for advanced non-small cell lung cancer2010
- Author(s)
  Inoue A
- Organizer
  KASLC annual meeting
- Place of Presentation
  Seoul, Korea
- Year and Date
  2010-11-19
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 小細胞肺がん2010
- Author(s)
  井上彰
- Organizer
  第51回日本肺癌学会総会
- Place of Presentation
  広島
- Year and Date
  2010-11-04
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] How to select patient for chemo or targeted agents.2010
- Author(s)
  Inoue A
- Organizer
  Chinese Conference on Medical Oncology
- Place of Presentation
  北京,中国
- Year and Date
  2010-07-26
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Recent topics about the individualized treatment for advanced non-small cell lung cancer.2010
- Author(s)
  Inoue A
- Organizer
  KASLC annual meeting
- Place of Presentation
  ソウル,韓国
- Year and Date
  2010-11-18
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 非小細胞肺癌に対する個別化治療の考え方2010
- Author(s)
  井上彰
- Organizer
  第49回日本肺癌学会中国・四国支部会
- Place of Presentation
  徳島
- Year and Date
  2010-07-17
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] A final results of a phase II study of first-line gefitinib for elderly patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations ; NEJ 003 study.2010
- Author(s)
  Inoue A
- Organizer
  ESMO congress
- Place of Presentation
  ミラノ,イタリア
- Year and Date
  2010-09-25
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] A final results of a phase II study of first-line gefitinib for elderly patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations ; NEJ 003 study2010
- Author(s)
  Inoue A, Minegishi Y, Maemondo M, Okinaga S, Morikawa N, Kobayashi K, Harada M, Hagiwara K, Nukiwa T, Gemma A
- Organizer
  ESMO congress
- Place of Presentation
  Milano
- Year and Date
  2010-10-10
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] The efficacy of low-dose gefitinib for advanced non-small cell lung cancer : A post-hoc analysis from NEJ0022010
- Author(s)
  Inoue A, Maemondo M, Kobayashi K, Oizumi S, Isobe H, Gemma A, Saijo Y, Hagiwara K, Morita S, Nukiwa T
- Organizer
  ASCO annual meeting
- Place of Presentation
  Chicago
- Year and Date
  2010-06-07
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] 切除不能局所進行非小細胞肺癌の化学放射線療法におけるUFT+ CDDP対VNR+ CDDPの無作為化比較第二相試験2010
- Author(s)
  榊原智博, 菅原俊一, 前門戸任, 石田卓, 臼井一裕, 井上彰, 石本修, 松原信行, 西條康夫, 貫和敏博
- Organizer
  第51回日本肺癌学会
- Place of Presentation
  広島
- Year and Date
  2010-11-03
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] What we can do afterpresent TKI failure- Acquired resistance?2010
- Author(s)
  Inoue A
- Organizer
  TSPCCM annual meeting
- Place of Presentation
  Taipei, Taipei
- Year and Date
  2010-12-11
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] プラセナ併用療法後の二次化学療法におけるS-1と隔週ドセタキセル併用療法の第二相試験2009
- Author(s)
  榊原智博, 井上彰, 石本修, 前門戸任, 松原信行, 森川直人, 奥寺弘一, 臼井一裕, 鈴木俊郎, 貫和敏博, 菅原俊一
- Organizer
  第50回日本肺癌学会
- Place of Presentation
  東京
- Year and Date
  2009-11-12
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] Star Trials from Japan 1 : EGFR変異遺伝子陽性の進行非小細胞肺癌における第III相試験(NEJ002)の中間解析結果2009
- Author(s)
  磯部宏, 井上彰, 小林国彦, 前門戸任, 菅原俊一, 大泉聡史, 西條康夫, 弦間昭彦, 森田智視, 萩原弘一, 貫和敏博
- Organizer
  第50回日本肺癌学会
- Place of Presentation
  東京
- Year and Date
  2009-11-12
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] ゲフィチニブ耐性例における個別化治療に関する検討2009
- Author(s)
  村上康司, 井上彰, 貫和敏博
- Organizer
  第49回日本呼吸器学会学術講演会
- Place of Presentation
  東京
- Year and Date
  2009-06-12
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] A randomized phase III study comparing gefitinib with carboplatin/paclitaxel for the first-line treatment of non-small cell lung cancer with sensitive EGFR mutations : NEJ002 study2009
- Author(s)
  Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Saijo Y, Gemma A, Morita S, Hagiwara K, Nukiwa T
- Organizer
  ECCO15/34^<th> ESMO multidisciplinary congress
- Place of Presentation
  Berlin
- Year and Date
  2009-09-22
- Data Source
  KAKENHI-PROJECT-21249052
[Presentation] I-CAMP: EGFR遺伝子変異陽性NSCLCに対するゲフィチニブ治療の統合解析2009
- Author(s)
  井上彰、朝比奈肇、砂長則明、須谷顕尚、吉田公秀、岡本勇、杉尾賢二、森田智視、小林国彦、貫和敏博、福岡正博
- Organizer
  第7回日本臨床腫瘍学会総会
- Place of Presentation
  名古屋
- Year and Date
  2009-03-20
- Data Source
  KAKENHI-PROJECT-19790552
[Presentation] Gefitinib provides an beneficial treatment to poor PS or s uper-elderly patients with EGFR mutation-positive NSCL C (North-East Japan Gefitinib Study Group)2008
- Author(s)
  Inoue A
- Organizer
  33^<rd> European Society of Medical Oncology
- Place of Presentation
  Stockholm(スウェーデン)
- Year and Date
  2008-09-15
- Data Source
  KAKENHI-PROJECT-19790552
[Presentation] Gefitinib provides an beneficial treatment to poor PS or super-elderly patients with EGFR mutation-positive NSCLC (North-East Japan Gefitinib Study Group).2008
- Author(s)
  Inoue A, et al
- Organizer
  33^r^d European Society of Medical Oncology, abstract 1391
- Place of Presentation
  Stockholm, Sweden
- Year and Date
  2008-12-09
- Data Source
  KAKENHI-PROJECT-19790552
[Presentation] Phase II study of 1^s^t line gefitinib for > PS 3 patient with advanced NSCLC with EGFR mutations.2007
- Author(s)
  Inoue A, et al
- Organizer
  The Meeting of Reunion Franco-Japonese on Clinical Oncology
- Place of Presentation
  Toulouse, France
- Year and Date
  2007-09-17
- Data Source
  KAKENHI-PROJECT-19790552
[Presentation] 肺腺癌EGFR活性型変異:基礎的意義と臨床試験での検証2007
- Author(s)
  井上彰
- Organizer
  第47回日本呼吸器学会総会教育講演
- Place of Presentation
  東京
- Year and Date
  2007-05-10
- Data Source
  KAKENHI-PROJECT-19790552
[Presentation] EGFR-TKIが教えてくれたこと．
- Author(s)
  井上　彰
- Organizer
  第53回日本肺癌学会
- Place of Presentation
  岡山
- Invited
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Randomized phase II trial comparing carboplatin with weekly paclitaxel and docetaxel alone for elderly patients with non-small cell lung cancer: NJLCG0803.
- Author(s)
  井上　彰
- Organizer
  第10回日本臨床腫瘍学会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] Preliminary results from a prospective study of systemic chemotherapy with carboplatin plus amrubicine for thymic malignancies.
- Author(s)
  Inoue A
- Organizer
  3rd ITMIG meeting
- Place of Presentation
  Fukuoka
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 肺癌治療に関連する臨床的な知見．
- Author(s)
  井上　彰
- Organizer
  第32回日本画像医学会
- Place of Presentation
  東京
- Invited
- Data Source
  KAKENHI-PROJECT-22790746
[Presentation] 進行肺がんの薬物療法．
- Author(s)
  井上　彰
- Organizer
  第7回医療の質・安全学会
- Place of Presentation
  大宮
- Invited
- Data Source
  KAKENHI-PROJECT-22790746

1. NUKIWA Toshihiro (40129036)

# of Collaborated Projects: 3 results

# of Collaborated Products: 20 results
2. KIKUCHI Toshiaki (10280926)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
3. FUKUHARA Tatsurou (80400365)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
4. OKOUCHI Shinya (40375035)

# of Collaborated Projects: 2 results

# of Collaborated Products: 9 results
5. EBINA Masahito (10280885)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
6. SAKAKIBARA Tomohiro (80422111)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
7. KANEHIRA Masahiko (90374941)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. HAGIWARA Kouichi (00240705)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results
9. KONDOH Takahshi (10195901)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. SATO Yasufumi (50178779)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. TAMADA Tsutomu (80396473)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. HISATA Shu (60466571)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. OHTA Hiromitsu (40451562)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. MATSUBARA Yoichi (00209602)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. SUZUKI Takuji (80344670)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. NISHIO Kazuto (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. Irokawa Toshiya (70375179)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
18. Ogawa Hiromasa (90361162)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
19. Kurosawa Hajime (60333788)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
20. Yamada Mitsuhiro (00396483)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 田原稔 (50375036)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. 前門戸任 (40344676)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
23. 森田達也 (70513000)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. 宮下光令 (90301142)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. 佐藤冨美子 (40297388)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. TODE Naoki

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. HIRANO Taizou

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
28. HIROSE Masaki

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
29. SUGIURA Hisatoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
30. MIKI Yasuhiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
31. GENMA Akihiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
32. YOSHIZAWA Hirohisa

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
33. 田澤立之

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
34. 中田光

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
35. 井上義一

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
36. 一ノ瀬正和

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
37. 中山啓子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
38. 松本邦夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
39. 北村信隆

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
40. 石井晴之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
41. 熊本裕行

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
42. 曽田学

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
43. 田中伸幸

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
44. 西條康夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
45. 木下一郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Inoue Akira 井上 彰

INOUE Akira 井上 彰

Research Projects

Research Products

Co-Researchers

がん免疫療法看護の質評価指標開発に向けた探索的研究Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

がん悪液質による食欲不振・倦怠感に対する薬物療法の複合的研究Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

進行肺がん患者における抗がん剤治療の止めどきに関する多施設共同研究Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Differantial Mechanism of Lung Cells induced by Mesenchymal Stem Cells and the Treatment of Intractable Respiratory Diseases

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Familial pathogenesis of lung cancer with the epidermal growth factor receptor (EGFR) gene mutation

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Pathogenesis and control of circulating fibrocytes and miRNAs causing interstitial/airway fibrosis and initiating/promoting cancer in the lung

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Individualized treatment of lung cancer based on the resistant mutation in EGFR gene from circulating tumor cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Biological background for non-smoker lung adenocarcinoma : Why do EGFR somatic mutations accumulate on lung adenocarcinoma and on Asian ethnics?

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The analysis of mechanisms of interstitial lung disease induced by epidermal growth factor receptor inhibitor.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

肺腺癌EGFRキナーゼ活性型変異株はなぜ蛋白分解酵素阻害物質SLPIを高産生するか

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Activation mutations in EGF receptor kinase have the advantages of cell physiology in the bronchiolar region : Implication of anti-apoptotic signals and lung tumorigenesis and metastasis.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

NKG2Dリガンド遺伝子導入による抗腫瘍効果増強の検討Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis.2018

Author(s)

Journal Title

Inoue Akira 井上彰

INOUE Akira 井上彰